Papers: 10.1007/s00415-020-09835-y

https://doi.org/10.1007/s00415-020-09835-y

Long-term safety and efficacy of daclizumab beta in relapsing–remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study

Cited by: 6
Author(s): Ralf Gold, Ernst‐Wilhelm Radue, Gavin Giovannoni, Krzysztof Selmaj, Eva Havrdová, Xavier Montalbán, Dusan Stefoski, Till Sprenger, Randy R. Robinson, Sami Fam, Jonathan Smith, Spyros Chalkias, Giorgio Giannattasio, Gabriel Paiva da Silva Lima, Wanda Castro-Borrero
Published: about 5 years ago

Software Mentions 1